back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-03-17 15:30 Tx date 2022-03-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,000,000 vol |
3,000,000 | |
| Filed 2022-03-17 15:29 Tx date 2022-03-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-1,000,000 vol |
750,000 | |
| Filed 2022-02-24 17:37 Tx date 2022-02-17 |
$HYTN
HYTN Innovations Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2022-02-24 15:34 Tx date 2022-02-17 |
$HYTN
HYTN Innovations Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
571,429 | ||
| Filed 2022-02-15 19:25 Tx date 2022-02-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+500,000 vol |
1,750,000 | |
| Filed 2021-06-28 12:40 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+50,000 vol |
2,250,000 | |
| Filed 2021-06-28 12:39 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2021-06-28 12:37 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$100,000
+200,000 vol $0.50 each |
1,000,000 | |
| Filed 2021-06-28 12:37 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-200,000 vol |
600,000 | |
| Filed 2020-11-24 17:33 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$400,000
+800,000 vol $0.50 each |
||
| Filed 2020-11-24 17:29 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-800,000 vol |
||
| Filed 2021-01-27 20:17 Tx date 2021-01-25 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-1,000,000 vol |
1,000,000 | |
| Filed 2021-01-27 17:30 Tx date 2021-01-25 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,000,000 vol |
2,600,000 | |
| Filed 2020-11-24 17:33 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$400,000
+800,000 vol $0.50 each |
1,600,000 | |
| Filed 2020-11-24 17:29 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-800,000 vol |
0 | |
| Filed 2020-10-27 04:31 Tx date 2020-10-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,250,000 | |
| Filed 2020-10-15 16:22 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+1,000,000 vol |
2,000,000 | |
| Filed 2020-10-15 16:21 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
| Filed 2020-10-15 16:13 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 14:03 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 |